Navigation Links
InterMune to Present at Goldman Sachs Healthcare Conference
Date:6/3/2009

BRISBANE, Calif., June 3 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that Daniel Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the Goldman Sachs 30th Annual Global Healthcare Conference in New York on June 9, 2009 at 2:35 p.m. ET.

To access a live audio webcast of the presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone as a possible therapeutic candidate for the treatment of patients with IPF, RECAP, an open-label extension study from CAPACITY and a research program focused on small molecules for the treatment of pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche, its development partner) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating new targets in hepatology. For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.


'/>"/>
SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...lif., Nov. 18 Masimo (...(TM) and Measure-Through Motion and Low-Perfusion ...based Uni.H.A., one of the largest healthcare Grou...gned a multi-year purchasing agreement for "gold s...agreement offers preferred contract pricing to Uni...
(Date:11/18/2009)...ORK, Nov. 18 Reportlinker.com anno...le in its catalogue. ,, Biotechnology Reagent...ww.reportlinker.com/p0164375/Biotechnology-Reagent...newswire&utm_medium=pr&utm_campaign=prnews...mplex chemical compounds used in a range of biotec...
(Date:11/18/2009)... Promega Corporation and SwitchGear Genomics a...ein interactions. , Madis...orporation and SwitchGear Genomics announce a nove...ns. Results of a study using the HaloCHIP™ S...ate the ability to correlate DNA binding events to...
(Date:11/18/2009)...gnificantly reduces key cardiac enzymes at multipl...d at American Heart Association 2009 Scientific Se...iron Therapeutics Inc., a biotechnology company pi...ein therapeutics derived from pathogens, today rep...uating VT-111 (Serp-1), an anti-inflammatory prote...
Breaking Biology Technology:Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4
...nomy will have a different look and feel as tradit...3 1960) continue to exit the workforce, by choice...and nightmare - an excess of 10 million unfilled j...ll these positions. ,That does not leave much time...anies will be faced with some slap-in-the-face rea...
... UW-Madison Business Schools Weinert Applied Ventu... future for economic development in Wisconsin. , ... School of Entrepreneurship at the UW-Madison Sc...ind in Wisconsin. It is a state that has a lot of ... going on here at the university, we have WARF han...
...ennedy has focused his professional career on busi...the telecom and entertainment fields. Currently, h...the Sony Digital Networks Division , an align...SoapCity, Screenblast, the company,s mobile conten...ed platform service units. Mr. Kennedy also serves...
Other Biology Technology:The ON* is on the Employer 2WAVE of the Future? 2WAVE of the Future? 3WTN exclusive interview with Patrick Kennedy, exec. VP, Sony Pictures Digital 2WTN exclusive interview with Patrick Kennedy, exec. VP, Sony Pictures Digital 3WTN exclusive interview with Patrick Kennedy, exec. VP, Sony Pictures Digital 4
(Date:11/19/2009)...te fungus for food, have many remarkable qualities...t farmers, like their human counterparts, depend o...row. The finding, reported this week (Nov. 20) in ...own symbiosis between ants and bacteria and provid...dominate the American tropics and subtropics. , ...
(Date:11/19/2009)...ries of the world. It is widely used for human con...t also is considered an exemplar plant species for...genome architecture. The authors of the research p... description of the B73 maize genome to probe some...plant biology. The ten papers consider maize centr...
(Date:11/19/2009)...multi-institutional effort co-led by three Cold Sp...d today in publication of a landmark series of pap...ented detail the DNA sequence of maize ( Zea mays ...th American consumers, is one of the world,s most ...l crop grown in the United States, representing $4...
Breaking Biology News(10 mins):Like humans, ants use bacteria to make their gardens grow 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 1Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 2Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 3Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 4New drug for children with high risk leukemia 52965 1New drug for children with high risk leukemia 52965 2Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 1Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 2
...s. World records tumbled at the Beijing Olympics. ...records, knocking tenths of a second off each. Peo...ast few decades, which made marathon runner Mark D...t century,s massive increase in population could a...ndered whether there are absolute limits on runnin...
...r differentiations in the metabolic make-up of the...November 28 in the open-access journal PLoS Genet...y Karsten Suhre, has conducted a genome-wide assoc...c variants in genes involved in the breakdown of f...ty can affect individuals, susceptibility to compl...
...onmental threat has been detected in North America...rsities. , Along with scientists from several Can...nted biological damage caused by declining levels ... Calling the phenomenon "aquatic osteoporosis," Qu... the study, notes that calcium is an essential nut...
Other Biology News:100-meter sprint world record could go as low as 9.48 seconds 2Study identifies genetic variants giving rise to differences in metabolism 2Queen's University biologists find new environmental threat in North American lakes 2
Mouse Anti-Human QPCT Monoclonal Antibody, Unconjugated, Clone 4E11 from Novus Biologicals
Corning Erlenmeyer Flask, Pc, 250 ml, Plug Seal Cap, Sterile from Sigma-Aldrich
Bromothymol blue sodium salt from Sigma-Aldrich
SPRIStand - Magnetic 6-tube Stand from Agencourt Bioscience
Biology Products: